Here are relevant reports on : pension-administration-software-market
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End user (Hospitals, Clinics) - Global Forecast to 2029
The global veterinary vaccines market, valued at US$8.93 billion in 2023, stood at US$9.39 billion in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$13.33 billion by the end of the period.. Growing awareness of animal health, along with the rising pet population and ownership, is driving the adoption of veterinary vaccines. Government efforts to improve animal health and the increasing popularity of pet insurance are also contributing to this trend.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Pediatric Vascular Access Market by Type (Catheters (CVC, PIVC, PICC), Ports, IV Sets, Infusion Pumps), Application (Drug Administration, Blood Transfusion, Diagnostics & Testing), End User (Hospitals, ASCs) - Global Forecast to 2030
The global pediatric vascular access market, valued at US$0.51 billion in 2023, stood at US$0.54 billion in 2024 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$0.83 billion by the end of the period. The market for pediatric vascular access is driven by the increasing prevalence of preterm births, and advancements in pediatric care technologies are key factors fueling the growth of the pediatric vascular access market.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
IV Equipment Market by Product (Infusion Pump, Catheter, Solution and Blood Administration Set, Securement Device, Cannula, Stopcock, Needleless Connector), End User (Hospitals & Clinics, Homecare, Ambulatory Care Center) - Global Forecast to 2022
The global IV equipment market is expected to reach USD 13.63 Billion by 2022 from USD 10.07 Billion in 2017, at a CAGR of 6.2% from 2017 to 2022. The major factors driving the growth of this market include increasing incidence of chronic diseases, rapid growth in the aging population, and growing number of surgical procedures. The high growth in developing countries across Asia-Pacific and Latin America are expected to provide significant growth opportunities for players operating in the IV equipment market in the coming years.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Consumer Identity and Access Management (CIAM) Market by Solutions (Identity Administration, PII Management & Analytics, Access Management, Fraud Detection), Services, Authentication Type, and Vertical - Global Forecast to 2030
The global Consumer IAM market size is projected to grow from USD 14.12 billion in 2025 to USD 22.47 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 9.7 % during the forecast period. IBM (US), Okta (US), SAP (US), Microsoft (US), Ping Identity (US), Thales (France), Broadcom (US), AWS (US), Salesforce (US), OpenText (Canada), Akamai Technology (US), Deloitte (UK), HID Global (US), CyberArk (US), Nevis Security (Switzerland), Simeio Solutions (US), Ubisecure (Finland), OneLogin (US), SecureAuth (US), LoginRadius (Canada), IDology (US), Omada Identity (Denmark), WSO2 (US), WidasConcepts (Germany), FusionAuth (US), Transmit Security (Israel), IDnow (Germany), MiniOrange (US), Strivacity (US) are the key players and other players in the CIAM market.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028
The global veterinary API market, valued at US$8.0 billion in 2022, stood at US$8.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$11.9 billion by the end of the period. The veterinary active pharmaceutical ingredient (API) market is growing due to various factors, including the increased occurrence of transboundary and zoonotic diseases, a rise in the global animal population and pet ownership, and the implementation of improved disease control and prevention measures.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027
Veterinary pain management market growth is primed to transition from $1.8 billion in 2022 to $2.5 billion by 2027, showcasing a strong CAGR of 6.7%. Factors such as growth in companion animal adoption, the increasing number of veterinary practitioners and their rising income levels in developed economies, increasing consumption of meat & milk, the growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of this market.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
